Research chemical vendors: BPC-157 remains widely available online, labeled for research use only and not for human consumption
We follow your response, look at relevant labs over time, and adjust dosing or switch protocols when the data tells us to
The FDA has issued safety communications regarding compounded GLP-1 receptor agonists, including tirzepatide and semaglutide, warning about adverse events from bacterial contamination, incorrect dosing, and use of improper ingredients
In such cases, supplementation is often recommended
this is the most important contraindication Severe uncontrolled diabetes , GH antagonizes insulin and can worsen glycemic control Active proliferative diabetic retinopathy Pregnancy or breastfeeding Pituitary disorders or recent pituitary surgery Anyone considering tesamorelin should have a baseline workup that includes IGF-1, fasting glucose, HbA1c, a lipid panel, and a careful medical history, not just to establish baselines for monitoring, but to confirm tesamorelin is mechanistically the right tool before starting